These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 11585762

  • 1. Biochemical genetic analysis of indanocine resistance in human leukemia.
    Hua XH, Genini D, Gussio R, Tawatao R, Shih H, Kipps TJ, Carson DA, Leoni LM.
    Cancer Res; 2001 Oct 01; 61(19):7248-54. PubMed ID: 11585762
    [Abstract] [Full Text] [Related]

  • 2. Indanocine, a microtubule-binding indanone and a selective inducer of apoptosis in multidrug-resistant cancer cells.
    Leoni LM, Hamel E, Genini D, Shih H, Carrera CJ, Cottam HB, Carson DA.
    J Natl Cancer Inst; 2000 Feb 02; 92(3):217-24. PubMed ID: 10655438
    [Abstract] [Full Text] [Related]

  • 3. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.
    Ranganathan S, McCauley RA, Dexter DW, Hudes GR.
    Br J Cancer; 2001 Sep 01; 85(5):735-40. PubMed ID: 11531260
    [Abstract] [Full Text] [Related]

  • 4. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
    Kumar A, Soprano DR, Parekh HK.
    Cancer Res; 2001 Oct 15; 61(20):7552-5. PubMed ID: 11606393
    [Abstract] [Full Text] [Related]

  • 5. beta-Tubulin mutations are associated with resistance to 2-methoxyestradiol in MDA-MB-435 cancer cells.
    Gökmen-Polar Y, Escuin D, Walls CD, Soule SE, Wang Y, Sanders KL, Lavallee TM, Wang M, Guenther BD, Giannakakou P, Sledge GW.
    Cancer Res; 2005 Oct 15; 65(20):9406-14. PubMed ID: 16230404
    [Abstract] [Full Text] [Related]

  • 6. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
    Verrills NM, Po'uha ST, Liu ML, Liaw TY, Larsen MR, Ivery MT, Marshall GM, Gunning PW, Kavallaris M.
    J Natl Cancer Inst; 2006 Oct 04; 98(19):1363-74. PubMed ID: 17018783
    [Abstract] [Full Text] [Related]

  • 7. Tumor cells resistant to a microtubule-depolymerizing hemiasterlin analogue, HTI-286, have mutations in alpha- or beta-tubulin and increased microtubule stability.
    Poruchynsky MS, Kim JH, Nogales E, Annable T, Loganzo F, Greenberger LM, Sackett DL, Fojo T.
    Biochemistry; 2004 Nov 09; 43(44):13944-54. PubMed ID: 15518543
    [Abstract] [Full Text] [Related]

  • 8. Combretastatin A-4 resistance in H460 human lung carcinoma demonstrates distinctive alterations in beta-tubulin isotype expression.
    Wehbe H, Kearney CM, Pinney KG.
    Anticancer Res; 2005 Nov 09; 25(6B):3865-70. PubMed ID: 16309172
    [Abstract] [Full Text] [Related]

  • 9. Study of multi-drug resistant mechanisms in a taxol-resistant hepatocellular carcinoma QGY-TR 50 cell line.
    Zhou J, Cheng SC, Luo D, Xie Y.
    Biochem Biophys Res Commun; 2001 Feb 09; 280(5):1237-42. PubMed ID: 11162660
    [Abstract] [Full Text] [Related]

  • 10. Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol).
    Dumontet C, Duran GE, Steger KA, Beketic-Oreskovic L, Sikic BI.
    Cancer Res; 1996 Mar 01; 56(5):1091-7. PubMed ID: 8640766
    [Abstract] [Full Text] [Related]

  • 11. Binding of indanocine to the colchicine site on tubulin promotes fluorescence, and its binding parameters resemble those of the colchicine analogue AC.
    Das L, Gupta S, Dasgupta D, Poddar A, Janik ME, Bhattacharyya B.
    Biochemistry; 2009 Feb 24; 48(7):1628-35. PubMed ID: 19182899
    [Abstract] [Full Text] [Related]

  • 12. Interaction of microtubule depolymerizing agent indanocine with different human αβ tubulin isotypes.
    Kumbhar BV, Panda D, Kunwar A.
    PLoS One; 2018 Feb 24; 13(3):e0194934. PubMed ID: 29584771
    [Abstract] [Full Text] [Related]

  • 13. Intra-allelic suppression of a mutation that stabilizes microtubules and confers resistance to colcemid.
    Wang Y, Veeraraghavan S, Cabral F.
    Biochemistry; 2004 Jul 20; 43(28):8965-73. PubMed ID: 15248754
    [Abstract] [Full Text] [Related]

  • 14. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ, Wu CH, Choi MR, Najafi F, Emami A, Safa AR.
    Biochem Pharmacol; 2006 Jul 28; 72(3):293-307. PubMed ID: 16753135
    [Abstract] [Full Text] [Related]

  • 15. SRC tyrosine kinase and multidrug resistance protein-1 inhibitions act independently but cooperatively to restore paclitaxel sensitivity to paclitaxel-resistant ovarian cancer cells.
    George JA, Chen T, Taylor CC.
    Cancer Res; 2005 Nov 15; 65(22):10381-8. PubMed ID: 16288028
    [Abstract] [Full Text] [Related]

  • 16. Expression of class III beta-tubulin reduces microtubule assembly and confers resistance to paclitaxel.
    Hari M, Yang H, Zeng C, Canizales M, Cabral F.
    Cell Motil Cytoskeleton; 2003 Sep 15; 56(1):45-56. PubMed ID: 12905530
    [Abstract] [Full Text] [Related]

  • 17. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo.
    Wong VK, Chiu P, Chung SS, Chow LM, Zhao YZ, Yang BB, Ko BC.
    Clin Cancer Res; 2005 Aug 15; 11(16):6002-11. PubMed ID: 16115945
    [Abstract] [Full Text] [Related]

  • 18. Resistance to the tubulin-binding agents in renal cell carcinoma: no mutations in the class I beta-tubulin gene but changes in tubulin isotype protein expression.
    Ferguson RE, Taylor C, Stanley A, Butler E, Joyce A, Harnden P, Patel PM, Selby PJ, Banks RE.
    Clin Cancer Res; 2005 May 01; 11(9):3439-45. PubMed ID: 15867246
    [Abstract] [Full Text] [Related]

  • 19. Selective modulation of P-glycoprotein-mediated drug resistance.
    Bebawy M, Morris MB, Roufogalis BD.
    Br J Cancer; 2001 Dec 14; 85(12):1998-2003. PubMed ID: 11747345
    [Abstract] [Full Text] [Related]

  • 20. Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells.
    Banerjee A.
    Biochem Biophys Res Commun; 2002 Apr 26; 293(1):598-601. PubMed ID: 12054644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.